"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Descriptor ID |
D001172
|
MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 4 | 1 | 5 |
1996 | 2 | 1 | 3 |
1998 | 3 | 0 | 3 |
1999 | 6 | 1 | 7 |
2000 | 4 | 2 | 6 |
2001 | 5 | 0 | 5 |
2002 | 5 | 1 | 6 |
2003 | 11 | 1 | 12 |
2004 | 5 | 1 | 6 |
2005 | 10 | 1 | 11 |
2006 | 17 | 2 | 19 |
2007 | 8 | 1 | 9 |
2008 | 15 | 1 | 16 |
2009 | 14 | 2 | 16 |
2010 | 13 | 2 | 15 |
2011 | 8 | 3 | 11 |
2012 | 12 | 1 | 13 |
2013 | 6 | 1 | 7 |
2014 | 9 | 2 | 11 |
2015 | 6 | 2 | 8 |
2016 | 4 | 2 | 6 |
2017 | 13 | 4 | 17 |
2018 | 10 | 2 | 12 |
2019 | 11 | 1 | 12 |
2020 | 9 | 0 | 9 |
2021 | 8 | 0 | 8 |
2022 | 16 | 1 | 17 |
2023 | 9 | 0 | 9 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 01 18; 79(2):182-185.
-
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set. Semin Arthritis Rheum. 2024 Feb; 64:152343.
-
Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA. Front Immunol. 2023; 14:1290585.
-
Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clin Ther. 2023 09; 45(9):e177-e186.
-
Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116.
-
Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome. EBioMedicine. 2023 Jun; 92:104603.
-
Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Aug; 42(8):2053-2068.
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 07; 82(7):920-926.
-
Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply. Lancet Respir Med. 2023 06; 11(6):e52.
-
A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis. Proc Natl Acad Sci U S A. 2023 01 10; 120(2):e2211977120.